_(7184104335).webp)
Why Failure-to-Market Claims Are Preempted Under Federal Law
.png)
This short white paper addresses preemption arguments relevant to “failure to market” claims, which cover those cases in which plaintiffs allege that drug companies may be held liable for failing to bring to market, as quickly as possible, drugs that present (allegedly) fewer side effects than other, FDA-approved drugs already on the market.
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The claim rested on factual premises contradicted by all publicly available information, the acceptance of which could seriously disrupt the FDA approval process. This disruption gives rise to an issue the parties did not raise on appeal and that the appeals court never addressed, notwithstanding the complex, comprehensive statutes governing drug approval: these state tort law claims are preempted under theories of both field and conflict (including obstacle) preemption. This White Paper explains why it is imperative for the federal government and private parties to advance these preemption arguments, and why the courts should accept them.
Read the Issue Brief
This white paper was originally published by the Pacific Research Institute's Center for Medical Economics and Innovation.
Economic Dynamism
Dynamism and Stagnation: An Outlook
Flexibility and responsiveness are particularly important during periods of shock.
Recent Patterns of New Business Creation
The pandemic surge of new business entries highlights American entrepreneurial dynamism.
%20(1).webp)
.webp)
These Mayors Understand How to Run a City
Armed with common sense policies, three urban leaders are fighting a patient battle against chaos.
Saving Free Markets in America
American markets are under siege by interventionists on both the left and the right.
.webp)
A New Course Is Needed for the Steel Industry
It’s time for the steel industry and the government to get a divorce.
AI Disrupts Itself, Expect More of This
In a month, or perhaps sooner, another company will likely release an open source model that duplicates DeepSeek's feat and probably exceeds its accuracy and efficiency.
The EU Imposes Its ESG Agenda on American Companies
The goal in negotiating with the EU should be to secure the freer flow of goods, services, and investment, something in the interests of both America and the EU.
The Path Dependency of American Health Care
Health care policies promote the chance to acquire winning lottery tickets, offering greater health care services and product availability (subsidized by third parties) rather than better assurances of those resources being delivered and used more productively.
